mifepristone has been researched along with Compensatory Hyperinsulinemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heckmans, KML; Hoekstra, M; Houtman, R; Hunt, H; Koorneef, LL; Kroon, J; Meijer, OC; van Dorst, MMAR; Viho, EMG; Wahl, LF | 1 |
| Benthem, L; Boersma, G; Scheurink, AJ; Steimer, TJ; van Dijk, G | 1 |
2 other study(ies) available for mifepristone and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
The selective glucocorticoid receptor antagonist CORT125281 has tissue-specific activity.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Corticosterone; Hippocampus; Hyperinsulinism; Hyperlipidemias; Hypothalamo-Hypophyseal System; Liver; Mice; Mifepristone; Muscles; Pituitary-Adrenal System; Receptors, Glucocorticoid | 2020 |
Pharmacological treatment of hyperinsulineamia in rats depends on coping style.
Topics: Adaptation, Psychological; Animals; Blood Glucose; Disease Susceptibility; Glucose Tolerance Test; Hyperinsulinism; Hypoglycemic Agents; Insulin; Male; Mifepristone; Rats; Rosiglitazone; Thiazolidinediones | 2011 |